The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease (ILERVAS)
Randomized Intervention Study to Assess the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease and Its Impact on Morbidity and Mortality: The ILERVAS Project
Sponsor: Diputació de Lleida
This NA trial investigates Atherosclerosis and Chronic Kidney Diseases and is currently ongoing. Diputació de Lleida leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Sep 2022 — Apr 2024 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Sep 2022 [monthly]
Active Not Recruiting NA
▶ Show 4 earlier versions
-
Sep 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Sep 2019 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Diputació de Lleida
- Institut de Recerca Biomèdica de Lleida
- Jaume Arnó Renal Foundation
- Lleida Primary health care
- Unit of Detection and Treatment of Atherothrombotic diseases (UDETMA)
For direct contact, visit the study record on ClinicalTrials.gov .